5th Symposium on Emerging Treatments and Advances in Novel Cancer Therapies for Practicing Physician

Venue: InterContinental Dallas

Location: Dallas, Texas, United States

Event Date/Time: Jan 28, 2012 End Date/Time: Jan 28, 2012
Registration Date: Jan 28, 2012
Early Registration Date: Jan 10, 2012
Report as Spam


Statement of Need/Program Overview
This symposium is intended to improve care of cancer patients by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of solid tumors and hematological malignancies, this symposium will focus on individualized therapy based on emerging agents currently in development, symptom control and management of toxicity issues, and practice guidelines and its impact on reimbursement issues. The format will include didactic lectures from known thought leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. In-depth discussion of novel agents at various stages of clinical development will be given significant focus.

Target Audience
This symposium is directed primarily to hematologists, medical oncologists, radiation oncologists, surgical oncologists, researchers, pharmacists, registered nurses, physician assistants and nurse practitioners, fellows in training interested in new developments for treatment of various malignancies. No specific skill or knowledge other than a basic training in oncology is required for successful participation in this activity.
Learning Objectives
After completing this activity, the participant should be better able to:

Select lung cancer patients for appropriate targeted therapy based on histology along with predictive and prognostic markers
Identify breast cancer patients for treatment with integration of novel cytotoxic agents
Educate patients on the impact of combination therapy for colorectal cancer
Describe novel treatment options in the management of non-colorectal gastrointestinal cancer such as esophagogastric cancer, pancreatic cancer, hepatocellular carcinoma and neuroendocrine cancers
Utilize recent clinical data on the use of novel regimens in the treatment of leukemia
Prescribe novel treatment options for lymphoma
Educate patients on standard therapy and novel agent combinations in the treatment of multiple myeloma
Utilize appropriate new therapeutic options for prostate cancer and renal cell carcinoma
Choose between standard chemotherapy and novel therapeutic options for ovarian and gynecologic malignancies
Utilize appropriate new therapeutic options in the management of malignant melanoma
Evaluate the role of pharmacogenomics and their utility in individualized therapies
Utilize appropriate supportive cancer care in the era of targeted therapy
Discuss practice guidelines and its impact on reimbursement issues in the management of cancer treatment
Identify symptom management issues in the era of targeted chemotherapy


15201 Dallas Parkway
United States